Next Treatments
Back to Eczema

ICP-332

TypePill StagePhase 3 Latest updateNov 14, 2024Phase 3 study started

History

Earliest recorded event: Mar 18, 2023. This timeline shows events collected by Eczema Radar and may not include the treatment’s full history. Study details reflect the latest registry record available here.

  • Nov 14, 2024Phase 3 trial startedICP-332 in Subjects With Moderate to Severe Atopic Dermatitis ClinicalTrials.gov NCT06775860
  • Mar 18, 2023Phase 2 trial started · Status not confirmed by the sponsorPharmacodynamic Blood Characteristics of ICP-332 in Patients With Moderate to Severe Atopic Dermatitis ClinicalTrials.gov NCT05702268

Sources

Trials